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Background: Metabolic profiles predict future cardiac events and age is a strong clinical predictor of outcome. Using data from the MURDOCK CV 
Study we examined the extent to which baseline metabolic profiles vary with age.
methods: We performed targeted mass spectrometry profiling of 69 metabolites and routine lipid analysis on fasting plasma samples from 2002 
consecutive patients undergoing cardiac catheterization. Principle components analysis (PCA) was used to create 13 uncorrelated factors. We used 
linear regression to evaluate relationships between age and PCA factor levels. Factors whose levels varied significantly with age were assessed for 
association with death and death/MI using Cox proportional hazards regression.
results: Adjusted levels of 10 of the 13 factors varied significantly with age. For 8, levels increased with older age; for 2, they decreased (Table). 
Four factors independently predicted death and death/MI: Factor 1 (HRs 1.27 [95% CI, 1.11-1.46]; p=0.0007 and 1.15 [1.01-1.31]; p=0.032 
respectively), Factor 2 (HRs 1.21, [1.03-1.41];p=0.018 and 1.17 [1.02-1.35]; p=0.027), Factor 3 (HRs 1.26, [1.09-1.45]; p=0.0016 and 1.20 
[1.06-1.36]; p=0.0047), and Factor 12 (HRs 1.15, [1.01-1.30]; p=0.032 and 1.13 [1.01-1.27]; p=0.028). There were no age x factor level 
interactions.
conclusions: Baseline metabolic profiles vary with age. However, for factors that were associated with clinical outcomes, the associations were 
constant across the age continuum.
Adjusted Parameter Estimates of Factor Levels in Relation to Age Using Linear Regression
Factor 1 Medium-chain acylcarnitines 0.00384 p<0.0001
Factor 2 Short-chain dicarboxylacylcarnitines 0.00138 p<0.0001
Factor 3 Long-chain dicarboxylacylcarnititines 0.00261 p<0.0001
Factor 4 Ketone-related 0.00952 p<0.0001
Factor 5 Long-chain acylcarnitines 0.00174 p<0.0001
Factor 7 Cholesterol -0.00352 p<0.0001
Factor 9 Short-chain acylcarnitines 0.00681 p<0.0001
Factor 10 Medium-chain acylcarnitines 0.01453 p<0.0001
Factor 11 Lipids -0.01567 p<0.0001
Factor 12 Fatty acids 0.00716 p=0.0002
